What is Leerink Partnrs’ Forecast for ALDX Q1 Earnings?

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for Aldeyra Therapeutics in a research report issued on Sunday, April 13th. Leerink Partnrs analyst M. Goodman expects that the biotechnology company will earn ($0.27) per share for the quarter. The consensus estimate for Aldeyra Therapeutics’ […]